Intelligent Preformulation Design and Predictions Using Artificial Neural Networks

Preformulation in Solid Dosage Form Development

Volumn , Issue , 2008, Pages 81-114

  Ebube, Nkere K ^a  

^a Biovail Technologies Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952136205     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849360862-8     Document Type: Chapter

References (60)

1. Rowe RC, Roberts RJ. Intelligent Software for Product Formulation. London: Taylor & Francis, 1998, pp. 1-25.
2. Fonner DE Jr, Buck R, Banker GS. Mathematical optimization techniques in drug product design and process analysis. J Pharm Sci 1970; 59:1587-96.
3. Johnson AD, Anderson VL, Peck GE. A statistical approach for the development of an oral controlled release matrix tablet. Pharm Res 1990; 7: 1092-7.
4. Guo M, Kalra G, Wilson W, Peng Y, Augsburger LL. A prototype intelligent hybrid system for hard gelatin capsule formulation development. Pharm Technol 2002; 26(9):44-60.
5. Thieme RJ, Song M, Calantone RJ, Marinova D. Artificial neural network decision support systems for new product development project selection. J Market Res 2000; 37(4):499-514.
6. Porter ME. Competitive Advantage: Creating and Sustaining Superior Performance. New York: The Free Press, 1985.
7. Hussain AS, Yu X, Johnson RD. Application of neural computing in pharmaceutical product development. Pharm Res 1991; 8(10):1248-52.
8. Rowe RC, Colbourn EA. Pharma Visions 2002 (Spring Issue):4-7.
9. Rowe RC, Roberts RJ. Artificial intelligence in pharmaceutical product formulation: knowledge-based and expert systems. PSIT 1998; 1(4).
10. Turner J. Product formulation expert system. Manuf Intell 1991; (9):12-14.
11. Lai S, et al. An expert system to aid the development of capsule formulations. Pharm Technol Eur 1996; 8(9):60-8.
12. Bateman SD, Verlin J, Russo M, Guillot M, Laughlin SM. The development of a capsule formulation knowledge-based system. Pharm Tech 1996; 20(3): 174-84.
13. Thomas M. Manuf Intell 1991; (7):6-8.
14. Walczak B, Wegscheider W. Non-linear modeling of chemical data by combinations of linear and neural net methods. Anal Chem Acta 1993; 283: 508-17.
15. Anderson D, McNeill G. Artificial neural networks technology, a DACS stateof-the-art report. Kaman Sciences Corporation, NY, 1992.
16. McCulloch WS, Pitts W. A logical calculus of ideas immanent in nervous activity. Bulletin of Mathematical Biophysics 1943; 5:115-33. Reprinted in Anderson and Rosenfeld 1988.
17. Hebb DO. The Organization of Behavior. New York: Wiley 1949. Reprinted in Anderson and Rosenfeld 1988.
18. Rosenblatt F. Principles of Neurodynamics. New York: Spartan 1962.
19. Werbos P. Beyond regression: new tools for prediction and analysis in behavioral sciences. Ph.D. Thesis, Harvard University 1974.
20. Hopfield JJ. Neural networks and physical systems with emergent collective computational abilities. Proceedings of the National Academy of Sciences, USA 79, 2554-2558 (1982).
21. Hinton GE, Sejnowski TJ. Learning and relearning in Boltzmann machines. In Parallel Distributed Processing: Explorations in the Microstructure of Cognition, Vol 1. Cambridge Massachusetts: MIT Press 1986, pp. 282-317.
22. Rowe RC, Roberts RJ. Artificial intelligence in pharmaceutical product formulation: neural computing and emerging technologies. PSIT 1998; 1(5): 200-5.
23. Cheng B, Titterington DM. Neural networks: a review from a statistical perspective. Statist Sci 1994; 9(1):1-30 (reprint).
24. Randall J. Introduction to backpropagation neural network computation. Pharm Res 1993; 10(2): 165-70.
25. Hecht-Nielsen R. Kolmogorov’s mapping neural network existence theorem. In: Proc. First IEEE Int. Joint Conf. Neural Networks, San Diego, CA, June 21-24, 1987, pp. III-II-III-14.
26. Alvager T, Smith TJ, Vijay F. The use of artificial neural networks in biomedical technologies: an introduction. Biomed Instrum Technol 1994; July/August: 315-22.
27. Astion ML, Wener MH, Thomas RG, Hunder GG, Block DA. Overtraining in neural networks that interpret clinical data. Clin Chem 1993; 39(9): 1998-2004.
28. Hertz J, Krogh A, Palmer RG, eds. Introduction to the Theory of Neural Computation. California: Addison-Wesley, 1991, pp. 197-216.
29. Kohonen T. An adaptive associative memory principle. IEEE Trans Comp 1974; C-23:444-5.
30. Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cyber 1982; 43:59-69.
31. Kohonen T. Self-Organization and Associative Memory, 3rd edn. Berlin: Springer-Verlag, 1989.
32. Kohonen T, Barna G, Chrisley R. Statistical pattern recognition with neural networks: benchmarking studies. In: IEEE International Conference on Neural Networks, San Diego, 1988. New York: IEEE, 1988, vol. 1, pp. 61-8.
33. Kohonen T, Mäkisara, Saramäki T. Phonotopic maps-insightful representation of phonological features for speech recognition. In: Proceedings of the Seventh International Conference on Pattern Recognition, Montreal, 1984. New York: IEEE, 1984, pp. 182-5.
34. Myer RH. Classical and Modern Regression with Applications. Boston: Duxburry Press, 1986.
35. Sarle WS. Neural networks and statistical models. In: Proceedings of the 19th Annual SAS Users Group International Conference, April 1994.
36. Colbourn EA. In: Rowe RC, Roberts RJ, eds. Intelligent Software for Product Formulation. New York: Taylor and Francis, 1998, pp. 77-94.
37. Zadeh L. Fuzzy sets. Inform Control 1965; 8:338-53.
38. Bezdek JC. Fuzzy models…what are they, and why? IEEE Trans Fuzzy Systems 1993; 1(1):1-6.
39. Shao Q, Rowe RC, York P, Colbourn E. A comparison of two data mining technologies in the modeling of tablet formulation. In: Proceedings from AAPS Annual Conference, Salt Lake City, Utah, October 2003.
40. Hussain AS, Johnson RD, Vachharajani NN, Ritschel WA. Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data. Pharm Res 1993; 19(3):466-9.
41. Alvager T, Smith TJ, Vijai F. Neural network applications for analysis of adverse drug reactions. Biomed Instrum Technol 1993; September/October: 408-11.
42. Maclin PS, Dempsey J. How to improve a neural network for early detection of hepatic cancer. Cancer Lett 1994; 77:95-101.
43. Achanta AS, Kowalski JG, Rhodes CT. Artificial neural networks: implications for the pharmaceutical sciences. Drug Dev Ind Pharm 1995; 21: 119.
44. Takayama K, Fujikawa M, Nagai T. Artificial neural network as a novel method to optimize pharmaceutical formulations. Pharm Res 1999; 16:1.
45. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Application of artificial neural networks (ANN) in the development of solid dosage forms. Pharm Dev Technol 1997; 2(2):111-21.
46. Ebube NK, McCall T, Chen Y, Meyer MC. Relating formulation variables to in vitro dissolution using an artificial neural networks. Pharm Dev Technol 1997; 2(3):1-8.
47. Colbourn EA, Rowe RC. Neural computing boost formulation productivity, Pharm Technol IT innovations Supp 2003; 22-5.
48. Turkoglu M, Ozarslan R, Sakr A. Artificial neural network analysis of a direct compression tableting study. Eur J Pharm Biopharm 1995; 41:315-22.
49. Ebube NK, Owusu-Ababio G, Adeyeye CM. Preformulation studies and nondestructive characterization of the physicochemical properties of amorphous polymers using artificial neural networks. Int J Pharm 2000; 196:27-35.
50. Gasperlin M. Viscosity prediction of lipophilic semisolid emulsion systems by neural network modeling. Int J Pharm 2000; 196:37-50.
51. Agatonovic-Kustrin S, Alany RG. Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems. Pharm Res 2001; 18:1049-55.
52. Colbourn EA, Rowe RC. Modeling and optimization of a tablet formulation using neural networks and genetic algorithms. Pharm Technol Eur 1996; 8(9): 46-55.
53. Kurnik RT, Shah K, Ma X. Neural network modeling in drug delivery systems. Proc Int Symp Control Release Bioact Mater 1995; 22:368-9.
54. Takahara J, Takayama K, Nagai T. Multi-objective simultaneous optimization technique based on artificial neural network in sustained release formulations. J Control Rel 1997; 49:11-20.
55. Ford I, Rubinstein MH, McCaul F, Hogan JE, Edgar PJ. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methylcellulose matrix tablets. Int J Pharm 1987; 40:223-34.
56. Jha BK, Tambe SS, Kulkarni BD. Estimating diffusion coefficients of a micella system using an artificial neural network. J Colloid Interf Sci 1995; 170:392-8.
57. Khuri I, Conlon M. Simultaneous optimization of multiple responses represented by polynomial regression functions. Technometrics 1981; 23: 363-75.
58. Zografi G. States of water associated with solids. Drug Dev Ind Pharm 1988; 14:1905-26.
59. Ebube NK, Adeyeye CM. In: Proceedings of the AAPS Annual Meeting, Boston, MA, Nov 1997.
60. Kesavan JG, Peck GE. Pharmaceutical granulation and tablet formulation using neural networks. Pharm Dev Technol 1996; 1(4):391-404.